AUTHOR=Opazo-Ríos Lucas , Tejera-Muñoz Antonio , Soto Catalan Manuel , Marchant Vanessa , Lavoz Carolina , Mas Fontao Sebastián , Moreno Juan Antonio , Fierro Fernandez Marta , Ramos Ricardo , Suarez-Alvarez Beatriz , López-Larrea Carlos , Ruiz-Ortega Marta , Egido Jesús , Rodrigues-Díez Raúl R. TITLE=Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice JOURNAL=Frontiers in Pharmacology VOLUME=13 YEAR=2022 URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.778776 DOI=10.3389/fphar.2022.778776 ISSN=1663-9812 ABSTRACT=
Diabetic nephropathy (DN) is the main leading cause of chronic kidney disease worldwide. Although remarkable therapeutic advances have been made during the last few years, there still exists a high residual risk of disease progression to end-stage renal failure. To further understand the pathogenesis of tissue injury in this disease, by means of the Next-Generation Sequencing, we have studied the microRNA (miRNA) differential expression pattern in kidneys of Black and Tan Brachyury (BTBR) ob/ob (leptin deficiency mutation) mouse. This experimental model of type 2 diabetes and obesity recapitulates the key histopathological features described in advanced human DN and therefore can provide potential useful translational information. The miRNA-seq analysis, performed in the renal cortex of 22-week-old BTBR ob/ob mice, pointed out a set of 99 miRNAs significantly increased compared to non-diabetic, non-obese control mice of the same age, whereas no miRNAs were significantly decreased. Among them, miR-802, miR-34a, miR-132, miR-101a, and mir-379 were the most upregulated ones in diabetic kidneys. The